These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1279253)
1. Nebracetam (WEB 1881FU) prevents N-methyl-D-aspartate receptor-mediated neurotoxicity in rat striatal slices. Kataoka Y; Niwa M; Koizumi S; Watanabe S; Kouzuma M; Taniyama K Jpn J Pharmacol; 1992 Jun; 59(2):247-50. PubMed ID: 1279253 [TBL] [Abstract][Full Text] [Related]
2. Contribution of L-type Ca2+ channels to long-term enhancement of high K(+)-evoked release of dopamine from rat striatal slices. Koizumi S; Kataoka Y; Inoue K; Kohzuma M; Niwa M; Taniyama K Neurosci Lett; 1995 Mar; 187(2):123-6. PubMed ID: 7540271 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory action of nebracetam on various stimuli-evoked increases in intracellular Ca2+ concentrations in cultured rat cerebellar granule cells. Kataoka Y; Kohno Y; Watanabe Y Jpn J Pharmacol; 1995 Jan; 67(1):87-90. PubMed ID: 7745850 [TBL] [Abstract][Full Text] [Related]
4. Modulation of nicotine-evoked [3H]dopamine release from rat striatal synaptosomes by voltage-sensitive calcium channel ligands. Prince RJ; Fernandes KG; Gregory JC; Martyn ID; Lippiello PM Biochem Pharmacol; 1996 Aug; 52(4):613-8. PubMed ID: 8759034 [TBL] [Abstract][Full Text] [Related]
5. NMDA receptor involvement in endothelin neurotoxicity in rat striatal slices. Kataoka Y; Koizumi S; Kohzuma M; Shibaguchi H; Shigematsu K; Niwa M; Taniyama K Eur J Pharmacol; 1995 Feb; 273(3):285-9. PubMed ID: 7537685 [TBL] [Abstract][Full Text] [Related]
6. Complex influence of the L-type calcium-channel agonist BayK8644(+/-) on N-methyl-D-aspartate responses and neuronal survival. Barger SW Neuroscience; 1999 Mar; 89(1):101-8. PubMed ID: 10051220 [TBL] [Abstract][Full Text] [Related]
7. 1-Hydroxy-3-aminopyrrolid-2-one (HA-966) and kynurenate antagonize N-methyl-D-aspartate induced enhancement of [3H]dopamine release from rat striatal slices. Crawford M; Roberts PJ Biochem Pharmacol; 1989 Dec; 38(23):4165-8. PubMed ID: 2688655 [TBL] [Abstract][Full Text] [Related]
8. Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat. Nash JE; Brotchie JM Mov Disord; 2002 May; 17(3):455-66. PubMed ID: 12112191 [TBL] [Abstract][Full Text] [Related]
10. Region-dependent dynamics of cAMP response element-binding protein phosphorylation in the basal ganglia. Liu FC; Graybiel AM Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4708-13. PubMed ID: 9539803 [TBL] [Abstract][Full Text] [Related]
11. Effects of L- and N-type Ca2+ channel antagonists on excitatory amino acid-evoked dopamine release. Chaudieu I; Alonso R; Mount H; Quirion R; Boksa P Eur J Pharmacol; 1992 Sep; 220(2-3):203-9. PubMed ID: 1385182 [TBL] [Abstract][Full Text] [Related]
12. Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. Cepeda C; Colwell CS; Itri JN; Chandler SH; Levine MS J Neurophysiol; 1998 Jan; 79(1):82-94. PubMed ID: 9425179 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effect of WEB 1881 FU (nebracetam) on an ischemia-induced deficit of glucose uptake in rat hippocampal and cerebral cortical slices and CA1 field potential in hippocampal slices. Shibata S; Kagami-ishi Y; Ueki S; Watanabe S Jpn J Pharmacol; 1992 Mar; 58(3):243-50. PubMed ID: 1355146 [TBL] [Abstract][Full Text] [Related]
14. Influence of a Ca2+ channel agonist, Bay k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists. Czuczwar SJ; Gasior M; Turski WA; Kleinrok Z Eur J Pharmacol; 1994 Oct; 264(1):103-6. PubMed ID: 7530200 [TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity. Poeggeler B; Rassoulpour A; Wu HQ; Guidetti P; Roberts RC; Schwarcz R Neuroscience; 2007 Aug; 148(1):188-97. PubMed ID: 17629627 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of N-methyl-D-aspartate-stimulated dopamine release from rat brain slices by aluminum fluoride and carbachol. Woodward JJ; Harms J J Neurochem; 1992 Apr; 58(4):1547-54. PubMed ID: 1532197 [TBL] [Abstract][Full Text] [Related]
17. Effects of nebracetam on synaptosomal monoamine uptake of striatal and hippocampal regions in rats. Takeo S; Hayashi H; Tadokoro M; Takagi K; Miyake K; Takagi N; Oshikawa S Biol Pharm Bull; 1997 Apr; 20(4):360-3. PubMed ID: 9145210 [TBL] [Abstract][Full Text] [Related]
18. Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine. Mela F; Marti M; Fiorentini C; Missale C; Morari M Mol Cell Neurosci; 2006 Feb; 31(2):284-92. PubMed ID: 16249096 [TBL] [Abstract][Full Text] [Related]
19. Role of nerve terminal L-type Ca2+ channel in the brain. Watanabe Y; Lawlor GF; Fujiwara M Life Sci; 1998; 62(17-18):1671-5. PubMed ID: 9585155 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of D2 dopamine receptors decreases intracellular calcium levels in rat anterior pituitary cells but not striatal synaptosomes: a flow cytometric study using indo-1. Wolf ME; Kapatos G Synapse; 1989; 4(4):353-70. PubMed ID: 2481345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]